The US agency has updated its emergency use authorization template for developers making home-use coronavirus serology tests that use fingersticks to collect blood samples.
The US Food and Drug Administration has tweaked its emergency use authorization (EUA) template for developers making home-use COVID-19 serology tests that use fingersticks to collect blood samples.
The template, “Home Specimen Collection Serology Template for Fingerstick Dried Blood Spot,” was updated on 24 March “to add clarity throughout and provide updated recommendations for pre-collection stability,” the...
The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.
Cardiosense has launched a nationwide clinical study, SEISMIC-HF II, to validate its non-invasive, AI-powered technology for monitoring heart failure. The data will be used to file for US regulatory clearance of the Cardiosense heart failure monitoring platform.
Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.
Roche aims to grow its diagnostics sales by mid to high single digits, said CEO of Roche Diagnostics Matt Sause. The company unveiled the Axelios synthesis and sequencing solution and discussed its “long-term commitment” to China, as well as its business strategy for the next five years.
